UK markets closed

Alaunos Therapeutics, Inc. (WEK.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.58000.0000 (0.00%)
At close: 08:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
6
5
2,922
398
0
-
Operating expenses
Research development
9,901
16,279
25,018
49,643
52,696
-
Selling general and administrative
10,668
12,219
13,142
27,564
27,665
-
Total operating expenses
20,569
28,498
38,160
77,207
80,361
-
Operating income or loss
-20,563
-28,493
-35,238
-76,809
-80,361
-
Interest expense
1,068
1,921
3,154
1,189
0
-
Total other income/expenses net
-5,143
-4,726
662
-753
385
-
Income before tax
-26,774
-35,140
-37,730
-78,751
-79,976
-
Income from continuing operations
-26,774
-35,140
-37,730
-78,751
-79,976
-
Net income
-26,774
-35,140
-37,730
-78,751
-79,976
-
Net income available to common shareholders
-26,774
-35,140
-37,730
-78,751
-79,976
-
Basic EPS
-
-
-
-
-0.38
-0.70
Diluted EPS
-
-
-
-
-0.38
-0.70
Basic average shares
-
-
-
-
209,636
167,952
Diluted average shares
-
-
-
-
209,636
167,952